Cite
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
MLA
Νarjes Nasiri-Ansari, et al. “Canagliflozin Attenuates the Progression of Atherosclerosis and Inflammation Process in APOE Knockout Mice.” Cardiovascular Diabetology, vol. 17, no. 1, July 2018, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12933-018-0749-1.
APA
Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, & Eva Kassi. (2018). Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice. Cardiovascular Diabetology, 17(1), 1–12. https://doi.org/10.1186/s12933-018-0749-1
Chicago
Νarjes Nasiri-Ansari, Georgios K. Dimitriadis, Georgios Agrogiannis, Despoina Perrea, Ioannis D. Kostakis, Gregory Kaltsas, Athanasios G. Papavassiliou, Harpal S. Randeva, and Eva Kassi. 2018. “Canagliflozin Attenuates the Progression of Atherosclerosis and Inflammation Process in APOE Knockout Mice.” Cardiovascular Diabetology 17 (1): 1–12. doi:10.1186/s12933-018-0749-1.